Expertise in
4
conditions

Shaoliang F. Chen

68 Changle Rd, 
Nanjing, CN 
Expertise in
4
conditions
68 Changle Rd, 
Nanjing, CN 

Overview

Shaoliang Chen practices practicing medicine in Nanjing, China.

Chen is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Cerebral Hypoxia, Heart Attack, Percutaneous Coronary Intervention (PCI), and Stent Placement.

They are actively involved in clinical research, co-authoring 120 peer reviewed articles and participating in 6 clinical trials.

Locations

68 Changle Rd, Nanjing, 210006, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Comparison of Intravascular Ultrasound-guided With Angiography-guided Double Kissing Crush Stenting Technique for Patients With Complex Coronary Bifurcation Lesions: The Prospective, Multi-center, Randomized DKCRUSH VIII Trial
Comparison of Intravascular Ultrasound-guided With Angiography-guided Double Kissing Crush Stenting Technique for Patients With Complex Coronary Bifurcation Lesions: The Prospective, Multi-center, Randomized DKCRUSH VIII Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting in the Treatment of True Bifurcation Lesions: a Multicenter, Noninferior, Randomized, Controlled Trial (the DK Culotte-I Study)
Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting in the Treatment of True Bifurcation Lesions: a Multicenter, Noninferior, Randomized, Controlled Trial (the DK Culotte-I Study)
Enrollment Status: Completed
Publish Date: September 27, 2022
Intervention Type: Device
Study Phase: Not Applicable
Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk: A Randomized, Single-center, Pilot Study
Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk: A Randomized, Single-center, Pilot Study
Enrollment Status: Completed
Publish Date: April 26, 2022
Intervention Type: Device
Study Phase: Not Applicable
Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Percutaneous Coronary Intervention: The PL-PLATELET Randomized Trial
Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Percutaneous Coronary Intervention: The PL-PLATELET Randomized Trial
Enrollment Status: Withdrawn
Publish Date: August 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-comers Coronary Lesions （ULTIMATE Trial）
Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-comers Coronary Lesions （ULTIMATE Trial）
Enrollment Status: Completed
Publish Date: November 03, 2020
Intervention Type: Procedure
Study Phase: Not Applicable
Prevalence of Vulnerable Plaque Its Location and Clinical Significance in Bifurcation Lesions Detected by Optical Coherence Tomography.
Prevalence of Vulnerable Plaque Its Location and Clinical Significance in Bifurcation Lesions Detected by Optical Coherence Tomography.
Enrollment Status: Completed
Publish Date: July 30, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 5 Less Clinical Trials

120 Total Publications

Clopidogrel Versus Dual-Antiplatelet Therapy for Long-Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT-BIRISK Trial.
Clopidogrel Versus Dual-Antiplatelet Therapy for Long-Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT-BIRISK Trial.
Journal: Journal of the American Heart Association
Published: August 20, 2026

Frequently Asked Questions about Shaoliang F. Chen

Is Shaoliang F. Chen a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Shaoliang F. Chen is classified as an Advanced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shaoliang F. Chen participate in research or clinical trials?

Yes. Shaoliang F. Chen has published 120 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Shaoliang F. Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile